WE ARE ZANOVEO
Innovating Healthcare
We offer comprehensive end-to-end market entry platform, to bring innovative healthcare solutions to
patients in markets of greatest unmet medical needs.
WE ARE ZANOVEO
How We Do This
We focus on delivering innovative healthcare solutions to geographies where the unmet needs are high. Emerging and developing economies are typically at the distant end of big pharma launches. We aim to bridge this gap by being a partner of choice for bringing innovative healthcare solutions to these markets in tandem with the developed world.
Patient outcomes focussed
Innovation led
Collaborative approach
Performance driven
WE ARE ZANOVEO
GET TO KNOW US
Removing Access Barriers
Many innovative bio-pharmaceutical companies need the right partner to help bring their innovations to
the highly complex and competitive landscape of developing economies with under-developed
regulatory systems, risky IP environment and uncertain pricing and reimbursement mechanisms. We at
Zanoveo can help support you every step of the way to better enhance access to your innovative
products.
From delivering critical market insights to managing your regulatory milestones and developing an
integrated product strategy for market entry, we work with you to strategize and plan your commercial
readiness.
Product Lifecycle Management
Increasingly stakeholders, from physicians to patients, need more value from therapies. It is essential to
uncover the hidden value in your brand, demonstrated through improved efficacy, alternate delivery
methods, increasing patient compliance, and more. Product lifecycle management emphasizes the
entire lifecycle, from discovery to end of life and not just launch to patent expiry.
Strengthening market presence, monitoring the competition, regular performance review, assisting with
product life cycle extension, strategizing entry into new markets and market segments; we help
strategically plan and maximize product value.
partner with Zanoveo
We aspire to be the partner of choice for innovative bio-pharmaceutical companies, providing them with
a commercialisation powerhouse that is focused on timely patient access first, commercial excellence,
and geographical reach powered by deep industrial expertise.